Working... Menu

Child Asthma : What Parents Attitude During an Asthma Attack at Home Before Consulting the Pediatric Emergencies (ASPECT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03967873
Recruitment Status : Recruiting
First Posted : May 30, 2019
Last Update Posted : May 30, 2019
Information provided by (Responsible Party):
University Hospital, Brest

Brief Summary:

prospective multicenter observational study. Parents whose children meet the inclusion criteria complete a questionnaire assessing the child's follow-up, the management of the current asthma attack, and the treatment provided at home.

The main objective is to calculate the prevalence of placement of short-acting bronchodilators. The secondary objectives are to describe the factors associated with their implementation.

Condition or disease
Asthma in Children Asthma Attack Therapeutic Adherence

Layout table for study information
Study Type : Observational
Estimated Enrollment : 350 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Prevalence of Preoperative Short-acting Mimetic beta2 Therapy by Parents of Asthmatic Children Attending Emergency Room for Asthma Attack
Actual Study Start Date : October 9, 2018
Estimated Primary Completion Date : December 31, 2019
Estimated Study Completion Date : January 31, 2020

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Asthma

Primary Outcome Measures :
  1. prevalence of short-acting bronchodilator induction in children attending emergency room for asthma attack [ Time Frame: 1 hour ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   2 Years to 15 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
children between 2 and 15 years old in Quimper or Brest emergency department for asthma attacks whose parents agree to fill in a questionnaire about their pre-hospital attitude.

Inclusion Criteria:

  • child over 2 years emergency room consultant for asthma attack
  • child whose parents did not express their opposition to participate and completed the non-objection form
  • child consultant in pediatric emergencies of Quimper and Brest

Exclusion Criteria:

  • child whose age is not between 2 and 15 years old
  • cough equivalent of asthma
  • history of cardiac or pulmonary pathology or prematurity
  • refusal to participate

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT03967873

Layout table for location contacts
Contact: CROS Pierrick 02-98-22-36-59

Layout table for location information
CHRU de Brest Recruiting
Brest, France, 29609
Contact: CROS Pierrick         
Ch Quimper Recruiting
Quimper, France, 29000
Contact: Lapostolle Claire         
Sponsors and Collaborators
University Hospital, Brest

Layout table for additonal information
Responsible Party: University Hospital, Brest Identifier: NCT03967873     History of Changes
Other Study ID Numbers: ASPECT (29BRC18.0201)
First Posted: May 30, 2019    Key Record Dates
Last Update Posted: May 30, 2019
Last Verified: February 2019

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:
Layout table for MeSH terms
Bronchial Diseases
Respiratory Tract Diseases
Lung Diseases, Obstructive
Lung Diseases
Respiratory Hypersensitivity
Hypersensitivity, Immediate
Immune System Diseases
Disease Attributes
Pathologic Processes